What's happening
This bill creates a program to investigate and track unsafe prescription drug reimportation in New York, including a public registry of involved websites and entities.
Why it matters
Creates a centralized, statewide system for investigating potentially unsafe or illegal prescription drug imports. , aiming to catch both individual and organized actors selling or facilitating the sale of drugs from other countries, especially via the internet.
Mandates rapid sharing of information and coordination among law enforcement, health agencies, and federal authorities. , increasing the likelihood of stopping dangerous drugs before they reach consumers and possibly deterring criminal activity by increasing oversight.
Establishes a public online registry listing websites and entities involved in reimporting prescription drugs, including complaint and conviction histories. , which can help consumers make safer choices and increase transparency around sources of imported medications.
Provides legal protections for individuals and officials who report suspected violations in good faith. , encouraging whistleblowing and reporting without fear of retaliation or lawsuits, which could lead to more effective enforcement and greater public safety.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
New York State Police
The bill would require the division to establish an unsafe-drug reimportation investigation program, investigate complaints and coordinate agency responses.
New York State Department of Health
The department would have to publish an online registry of foreign prescription drug sellers, including complaint counts, known convictions and federal import authorization status.
Websites and middlemen selling prescription drugs from other countries
Their operations could face State Police investigations and inclusion in the health department’s public registry.
New Yorkers reporting suspected unsafe drug imports
The bill would require investigations of their complaints and provide civil and criminal liability protections for good-faith reporting under the program.
Headline styles
Stop Unsafe Drug Imports
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Referred to governmental operations
- Referred to governmental operations
Full text
3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
4095
2019-2020 Regular Sessions
IN ASSEMBLY
February 1, 2019
Introduced by M. of A. ENGLEBRIGHT -- read once and referred to the Committee on Governmental Operations
AN ACT to amend the executive law and the public health law, in relation to the prescription drug reimportation protection program
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The executive law is amended by adding a new section 216-e to read as follows:
§ 216-e. Prescription drug reimportation protection program. 1. The superintendent of state police shall establish a program to investigate actual and/or suspected cases of reimportation of unsafe drugs within this state and may assign employees as deemed necessary for the proper operation of such program.
2. The program shall provide that the division of state police may investigate, as provided in this section, any internet website which offers or provides a mechanism to sell prescription drugs to consumers in New York from another country or any entity acting as a middleman or agent in the importation or reimportation for sale of prescription drugs from other countries. The program shall provide that the division of state police shall investigate any complaint from a government official, or from an individual, claiming that prescription drugs being imported or reimported by such entity or through such website are adulterated or mislabeled or otherwise in violation of section sixty-eight hundred eleven of the education law.
3. The program shall further provide that the division of state police shall act as the coordinating agency responding to cases of suspected importation or reimportation of prescription drugs in a manner that is in violation of such section sixty-eight hundred eleven of the education law. The superintendent of state police shall by regulation establish uniform procedures for investigation and the receipt of such complaints from other agencies involved in such cases.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD08461-01-9
A. 4095 2
4. The superintendent of state police, in cooperation with the department of health, the division of criminal justice services, the department of agriculture and markets and other pertinent agencies, shall promulgate such additional rules and regulations which in the superintendent's discretion are necessary for the efficient operation of this section. These regulations shall include but not be limited to the following:
a. the establishment of uniform procedures to be used whenever a law enforcement or regulatory agency or other agency becomes involved in a suspected importation or reimportation of prescription drugs in a manner that is in violation of such section sixty-eight hundred eleven of the education law. Such regulations shall require that the division of state police provide direct investigative assistance or support services to any law enforcement or regulatory agency upon request;
b. the establishment of a computerized central data base, located at division headquarters, which will function as an information management and retrieval system for such matters. Notification of all such cases made to law enforcement, regulatory agencies or other agencies shall be reported to the central data base within five hours of such notification;
c. authorization, upon request, to use the scientific crime detection laboratory to analyze evidence in connection with division of state police cases or cases that originate with other law enforcement, regulatory agencies or other agencies; and
d. reporting of all such complaints to the commissioner of health for use in the central registry which such commissioner is required to develop, and to the federal bureau of investigation, the federal food and drug administration and/or other appropriate federal agency charged with monitoring and prosecuting the importation or reimportation of drugs which are mislabeled or which show evidence of tampering or adulteration or other violations of state law.
5. Good faith reporting or disclosure pursuant to the division of state police and reports by such division to the department of health shall not constitute libel or slander or a violation of the right of privacy or privileged communication. Any person who in good faith reports cases of suspected importation or reimportation of prescription drugs in a manner that is in violation of section sixty-eight hundred eleven of the education law shall be immune from civil and criminal liability for any action taken in compliance with the provisions of this section.
§ 2. Section 206 of the public health law is amended by adding a new subdivision 31 to read as follows:
31. (a) The commissioner shall establish a registry of websites and entities which offer or provide a mechanism to sell prescription drugs to consumers in New York from another country and shall post such registry on a department website on the internet dedicated to providing information for such registry. Data to be published on such website shall include:
(i) the name of the website or entity which offers or provides a mechanism to sell prescription drugs to consumers in New York from another country,
(ii) the number of complaints concerning such website or entity,
(iii) convictions, if known, of the parties operating the website, for importing or reimporting prescription drugs which are adulterated or mislabeled or otherwise in violation of section sixty-eight hundred eleven of the education law,
A. 4095 3
(iv) whether the website or entity has permission from the appropriate federal agency to import or reimport prescription drugs into this country, and
(v) the website shall additionally provide a clear explanation of federal law concerning importation or reimportation of prescription drugs from another country into this country.
(b) Good faith reporting or disclosure by the commissioner pursuant to the requirements of this subdivision shall not constitute libel or slander or a violation of the right of privacy or privileged communication.
§ 3. This act shall take effect immediately.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.